Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tianjin Pharmaceutical Da Ren Tang Group, previously known as Tianjin Zhongxin Pharmaceutical, announced the release and listing of restricted A-shares under its 2019 Restricted A-Share Incentive Scheme. This move is part of the company’s ongoing efforts to incentivize its workforce and align their interests with shareholders, potentially impacting its stock performance positively.
For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.